Correlation Between ImmuPharma PLC and Sdiptech
Can any of the company-specific risk be diversified away by investing in both ImmuPharma PLC and Sdiptech at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining ImmuPharma PLC and Sdiptech into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between ImmuPharma PLC and Sdiptech AB, you can compare the effects of market volatilities on ImmuPharma PLC and Sdiptech and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in ImmuPharma PLC with a short position of Sdiptech. Check out your portfolio center. Please also check ongoing floating volatility patterns of ImmuPharma PLC and Sdiptech.
Diversification Opportunities for ImmuPharma PLC and Sdiptech
0.87 | Correlation Coefficient |
Very poor diversification
The 3 months correlation between ImmuPharma and Sdiptech is 0.87. Overlapping area represents the amount of risk that can be diversified away by holding ImmuPharma PLC and Sdiptech AB in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Sdiptech AB and ImmuPharma PLC is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on ImmuPharma PLC are associated (or correlated) with Sdiptech. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Sdiptech AB has no effect on the direction of ImmuPharma PLC i.e., ImmuPharma PLC and Sdiptech go up and down completely randomly.
Pair Corralation between ImmuPharma PLC and Sdiptech
Assuming the 90 days trading horizon ImmuPharma PLC is expected to generate 7.45 times more return on investment than Sdiptech. However, ImmuPharma PLC is 7.45 times more volatile than Sdiptech AB. It trades about 0.05 of its potential returns per unit of risk. Sdiptech AB is currently generating about -0.02 per unit of risk. If you would invest 249.00 in ImmuPharma PLC on October 12, 2024 and sell it today you would earn a total of 101.00 from holding ImmuPharma PLC or generate 40.56% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Strong |
| Accuracy | 100.0% |
| Values | Daily Returns |
ImmuPharma PLC vs. Sdiptech AB
Performance |
| Timeline |
| ImmuPharma PLC |
| Sdiptech AB |
ImmuPharma PLC and Sdiptech Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with ImmuPharma PLC and Sdiptech
The main advantage of trading using opposite ImmuPharma PLC and Sdiptech positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if ImmuPharma PLC position performs unexpectedly, Sdiptech can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Sdiptech will offset losses from the drop in Sdiptech's long position.| ImmuPharma PLC vs. Solstad Offshore ASA | ImmuPharma PLC vs. Coor Service Management | ImmuPharma PLC vs. Fonix Mobile plc | ImmuPharma PLC vs. Westlake Chemical Corp |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Alpha Finder module to use alpha and beta coefficients to find investment opportunities after accounting for the risk.
Other Complementary Tools
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data |